Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.

Biotechnology

Health Care

Entact Bio

The Watertown office focuses on advanced scientific research, particularly in data science and proteomics for biopharmaceutical development.

Watertown

This department manages high-level operational functions and supports executive leadership in organizational activities.

Executive Operations

The Biological Sciences Research team at Entact Bio focuses on advancing the understanding of deubiquitinase (DUB) biology and its implications for protein function in disease. Utilizing their expertise in chemical biology and small-molecule drug development, the team collaborates on the design and optimization of enhancement-targeting chimeric (ENTAC) medicines through the proprietary EncompassTM platform, ultimately driving the preclinical development of innovative therapeutic options.

Biological Sciences Research

This department focuses on advanced scientific research and exploration in various fields.

Research Sciences

This department oversees the strategic direction and governance of the organization through the board's leadership.

Board Governance

This department provides strategic direction and oversight for the organization.

Leadership

This department focuses on developing and guiding leadership roles within the organization.

People (2)

Jobs (0)

Other teams

Biological Sciences Research

Research Sciences

Board Governance

Leadership

Leadership Development